Andrew Fagan
Affiliations: | 1992-1994 | Physics | Trinity College - Dublin |
Google:
"Andrew Fagan"Mean distance: 366.27
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wang G, Xiong C, McDade EM, et al. (2018) Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 4: 669-676 |
| Suárez-Calvet M, Capell A, Araque Caballero MÁ, et al. (2018) CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. Embo Molecular Medicine |
| Twohig D, Rodriguez-Vieitez E, Sando SB, et al. (2018) The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease. Acta Neuropathologica Communications. 6: 130 |
| Gangishetti U, Christina Howell J, Perrin RJ, et al. (2018) Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimer's Research & Therapy. 10: 98 |
| Brier MR, Gordon B, Friedrichsen K, et al. (2016) Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease. Science Translational Medicine. 8: 338ra66 |
| Ryan DJ, Kenny RA, Christensen S, et al. (2015) Ischaemic stroke or TIA in older subjects associated with impaired dynamic blood pressure control in the absence of severe large artery stenosis. Age and Ageing. 44: 655-61 |
| Wang L, Benzinger TL, Hassenstab J, et al. (2015) Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease. Neurology. 84: 1254-60 |
| Fagan AM, Xiong C, Jasielec MS, et al. (2014) Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Science Translational Medicine. 6: 226ra30 |
| Blennow K, Zetterberg H, Fagan AM. (2012) Fluid biomarkers in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine. 2: a006221 |
| Tarawneh R, D'Angelo G, Macy E, et al. (2011) Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease. Annals of Neurology. 70: 274-85 |